Anixa Biosciences, Inc. (ANIX) Financials
ANIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| July 31, 2026 | 15.1 million | 1.9 million |
| April 30, 2026 | 14.9 million | 1.6 million |
| Jan. 31, 2026 | 15.2 million | 1.4 million |
| Oct. 31, 2025 | 16.1 million | 2.1 million |
ANIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| July 31, 2026 | -1.8 million | 609000 |
| April 30, 2026 | -1.7 million | 665000 |
| Jan. 31, 2026 | -2.6 million | 768000 |
| Oct. 31, 2025 | -1.3 million | 859000 |
ANIX Net Income
No data available :(
ANIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| July 31, 2026 | 13.9 million | - | 174000 |
| April 30, 2026 | 13.7 million | - | 184000 |
| Jan. 31, 2026 | 14.2 million | - | 151000 |
| Oct. 31, 2025 | 15.2 million | - | 163000 |
ANIX Shares Outstanding
ANIX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| July 31, 2026 | - | 1.3 million | 1.4 million | - |
| April 30, 2026 | - | 1.3 million | 1.4 million | - |
| Jan. 31, 2026 | - | 1.1 million | 1.6 million | - |
| Oct. 31, 2025 | - | 1.1 million | 1.7 million | - |
ANIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| July 31, 2026 | - | 10000 |
| April 30, 2026 | - | - |
| Jan. 31, 2026 | - | 10000 |
| Oct. 31, 2025 | - | 9000 |
ANIX
Price: $2.90
52 week price:
Earnings Per Share: -0.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 24809
Market Capitalization: 100.4 million